These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

458 related articles for article (PubMed ID: 11373406)

  • 1. Combination immunotherapy with soluble tumor necrosis factor receptors plus interleukin 1 receptor antagonist decreases sepsis mortality.
    Remick DG; Call DR; Ebong SJ; Newcomb DE; Nybom P; Nemzek JA; Bolgos GE
    Crit Care Med; 2001 Mar; 29(3):473-81. PubMed ID: 11373406
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the mortality and inflammatory response of two models of sepsis: lipopolysaccharide vs. cecal ligation and puncture.
    Remick DG; Newcomb DE; Bolgos GL; Call DR
    Shock; 2000 Feb; 13(2):110-6. PubMed ID: 10670840
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exogenous interleukin-10 fails to decrease the mortality or morbidity of sepsis.
    Remick DG; Garg SJ; Newcomb DE; Wollenberg G; Huie TK; Bolgos GL
    Crit Care Med; 1998 May; 26(5):895-904. PubMed ID: 9590320
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytokine blockade in sepsis--Are two better than one?
    Hotchkiss RS; Karl IE
    Crit Care Med; 2001 Mar; 29(3):671-2. PubMed ID: 11373443
    [No Abstract]   [Full Text] [Related]  

  • 5. Critical role of CD14 for production of proinflammatory cytokines and cytokine inhibitors during sepsis with failure to alter morbidity or mortality.
    Ebong SJ; Goyert SM; Nemzek JA; Kim J; Bolgos GL; Remick DG
    Infect Immun; 2001 Apr; 69(4):2099-106. PubMed ID: 11254563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunopathologic alterations in murine models of sepsis of increasing severity.
    Ebong S; Call D; Nemzek J; Bolgos G; Newcomb D; Remick D
    Infect Immun; 1999 Dec; 67(12):6603-10. PubMed ID: 10569781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunopathologic responses to non-lethal sepsis.
    Ebong SJ; Call DR; Bolgos G; Newcomb DE; Granger JI; O'Reilly M; Remick DG
    Shock; 1999 Aug; 12(2):118-26. PubMed ID: 10446892
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blockade of tumor necrosis factor reduces lipopolysaccharide lethality, but not the lethality of cecal ligation and puncture.
    Remick D; Manohar P; Bolgos G; Rodriguez J; Moldawer L; Wollenberg G
    Shock; 1995 Aug; 4(2):89-95. PubMed ID: 7496903
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of IL-6 and TNF in thermoregulation and survival during sepsis in mice.
    Leon LR; White AA; Kluger MJ
    Am J Physiol; 1998 Jul; 275(1):R269-77. PubMed ID: 9688988
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Azithromycin in Combination with Ceftriaxone Reduces Systemic Inflammation and Provides Survival Benefit in a Murine Model of Polymicrobial Sepsis.
    Patel A; Joseph J; Periasamy H; Mokale S
    Antimicrob Agents Chemother; 2018 Sep; 62(9):. PubMed ID: 29967025
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression and contribution of endogenous IL-13 in an experimental model of sepsis.
    Matsukawa A; Hogaboam CM; Lukacs NW; Lincoln PM; Evanoff HL; Strieter RM; Kunkel SL
    J Immunol; 2000 Mar; 164(5):2738-44. PubMed ID: 10679115
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Growth hormone and insulinlike growth factor I enhance host defense in a murine sepsis model.
    Inoue T; Saito H; Fukushima R; Inaba T; Lin MT; Fukatsu K; Muto T
    Arch Surg; 1995 Oct; 130(10):1115-22. PubMed ID: 7575126
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dehydroepiandrosterone decreases mortality rate and improves cellular immune function during polymicrobial sepsis.
    Oberbeck R; Dahlweid M; Koch R; van Griensven M; Emmendörfer A; Tscherne H; Pape HC
    Crit Care Med; 2001 Feb; 29(2):380-4. PubMed ID: 11246320
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Opposing effects of tumor necrosis factor receptor 1 and 2 in sepsis due to cecal ligation and puncture.
    Ebach DR; Riehl TE; Stenson WF
    Shock; 2005 Apr; 23(4):311-8. PubMed ID: 15803053
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipopolysaccharide-tumor necrosis factor-glucocorticoid interactions during cecal ligation and puncture-induced sepsis in mature versus senescent mice.
    Hyde SR; McCallum RE
    Infect Immun; 1992 Mar; 60(3):976-82. PubMed ID: 1541572
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential hazards of combination immunotherapy in the treatment of experimental septic shock.
    Opal SM; Cross AS; Jhung JW; Young LD; Palardy JE; Parejo NA; Donsky C
    J Infect Dis; 1996 Jun; 173(6):1415-21. PubMed ID: 8648214
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-inflammatory response is associated with mortality and severity of infection in sepsis.
    Ashare A; Powers LS; Butler NS; Doerschug KC; Monick MM; Hunninghake GW
    Am J Physiol Lung Cell Mol Physiol; 2005 Apr; 288(4):L633-40. PubMed ID: 15579629
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intrahepatic nuclear factor-kappa B activity and alpha 1-acid glycoprotein transcription do not predict outcome after cecal ligation and puncture in the rat.
    Chen J; Raj N; Kim P; Andrejko KM; Deutschman CS
    Crit Care Med; 2001 Mar; 29(3):589-96. PubMed ID: 11373425
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential sensitivity to Escherichia coli infection in mice lacking tumor necrosis factor p55 or interleukin-1 p80 receptors.
    Acton RD; Dahlberg PS; Uknis ME; Klaerner HG; Fink GS; Norman JG; Dunn DL
    Arch Surg; 1996 Nov; 131(11):1216-21. PubMed ID: 8911263
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is circulating endotoxin the trigger for the systemic inflammatory response syndrome seen after injury?
    Kelly JL; O'Sullivan C; O'Riordain M; O'Riordain D; Lyons A; Doherty J; Mannick JA; Rodrick ML
    Ann Surg; 1997 May; 225(5):530-41; discussion 541-3. PubMed ID: 9193181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.